fbpx
Medical Innovation Exchange

With its lead gene therapy nearing the clinic, SwanBio leans heavily on Syncona to close $56M series B

https://www.fiercebiotech.com/biotech/its-lead-gene-therapy-nearing-clinic-swanbio-leans-heavily-syncona-close-56m-series-b

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.